Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Placental group B Streptococcus is associated with increased risk of adverse foetal outcome

The placenta nourishes the foetus and supports its development and growth. Our study now identifies the placenta as a potential route for foetal infection with Streptococcus agalactiae (group B Streptococcus), as indicated by an exaggerated in utero inflammatory response and poor perinatal outcome when group B Streptococcus is detected in the placenta.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Placental GBS is associated with foetal cytokine storm.

References

  1. Gonçalves, B. P. et al. Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden. Lancet Glob. Health 10, e807–e819 (2021). A meta-analysis assessing poor maternal and foetal outcomes associated with GBS colonization during pregnancy.

    Article  Google Scholar 

  2. de Goffau, M. C. et al. Human placenta has no microbiome but can contain potential pathogens. Nature 572, 329–334 (2019). Our previous study investigating the placental microbiome.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kennedy, K. M. et al. Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies. Nature 613, 639–649 (2023). A perspective article discussing the presence of microorganisms in the intrauterine environment.

    Article  CAS  PubMed  Google Scholar 

  4. Madhi, S. A. et al. Potential for maternally administered vaccine for infant group B streptococcus. N. Engl. J. Med. 389, 215–227 (2023). Report from a phase 2 vaccine trial (C1091002) of the Pfizer hexavalent (serotypes Ia, Ib, II, III, IV and V) GBS conjugate vaccine (GBS6).

    Article  CAS  PubMed  Google Scholar 

  5. Gaccioli, F. et al. The pregnancy outcome prediction (POP) study: investigating the relationship between serial prenatal ultrasonography, biomarkers, placental phenotype and adverse pregnancy outcomes. Placenta 59, S17–S25 (2017). A review article on the POP study.

    Article  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Gaccioli, F. et al. Placental Streptococcus agalactiae DNA is associated with neonatal unit admission and foetal pro-inflammatory cytokines in term infants. Nat. Microbiol. https://doi.org/10.1038/s41564-023-01528-2 (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Placental group B Streptococcus is associated with increased risk of adverse foetal outcome. Nat Microbiol 9, 15–16 (2024). https://doi.org/10.1038/s41564-023-01539-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41564-023-01539-z

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing